QQ客服 官方微博 反馈留言

	Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study
	Liu, Kun; Song, Yanping; Xu, Gezhi; Ye, Jian; Wu, Zhifeng; Liu, Xiaoling; Dong, Xiaoguang; Zhang, Mingzhi; Xing, Yiqiao; Zhu, Shaoping
刊名	AMERICAN JOURNAL OF OPHTHALMOLOGY
	2019
卷号	197
ISSN号	0002-9394
DOI	10.1016/j.ajo.2018.08.026
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4263674
专题	武汉大学
推荐引用方式 GB/T 7714	Liu, Kun,Song, Yanping,Xu, Gezhi,et al. Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study[J]. AMERICAN JOURNAL OF OPHTHALMOLOGY,2019,197.
APA	Liu, Kun.,Song, Yanping.,Xu, Gezhi.,Ye, Jian.,Wu, Zhifeng.,...&Xu, Xun.(2019).Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study.AMERICAN JOURNAL OF OPHTHALMOLOGY,197.
MLA	Liu, Kun,et al."Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study".AMERICAN JOURNAL OF OPHTHALMOLOGY 197(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。